Publications by authors named "Peter Dunselman"

Claim this Profile
T
The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure.
Mattia A E Valente, Hans L Hillege, Gerjan Navis, Adriaan A Voors, Peter H J M Dunselman

Eur J Heart Fail· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preanalytical storage does not affect 99th percentile cardiac troponin T concentrations measured with a high-sensitivity assay.
Judith M Gillis, Peter Dunselman, Jochen Jarausch, Neletta de Jong, Christa M Cobbaert

Clin Chem· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary proteins in heart failure.
Mattia A E Valente, Kevin Damman, Peter H J M Dunselman, Hans L Hillege, Adriaan A Voors

Prog Cardiovasc Dis· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term impact of secondary preventive treatments in patients with stable angina.
Zoltán Vokó, Sophie de Brouwer, Jacobus Lubsen, Nicolas Danchin, Jan-Erik Otterstad, Peter H J M Dunselman

Eur J Epidemiol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
John J V McMurray, Peter Dunselman, Hans Wedel, John G F Cleland, Magnus Lindberg

J Am Coll Cardiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
Sally C Inglis, John J V McMurray, Michael Böhm, Maria Schaufelberger, Dirk J van Veldhuisen, Peter Dunselman

Eur J Heart Fail· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
Pim van der Harst, Riemer H J A Slart, Rene A Tio, Peter H J M Dunselman, Antoon T M Willemsen

Am J Cardiol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.
Paula K Lorgelly, Andrew H Briggs, Hans Wedel, Peter Dunselman, Ake Hjalmarson

Eur J Heart Fail· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
John J V McMurray, John Kjekshus, Lars Gullestad, Peter Dunselman, Ake Hjalmarson

Circulation· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
John G F Cleland, John J V McMurray, John Kjekshus, Jan H Cornel, Peter Dunselman

J Am Coll Cardiol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
Hans Wedel, John J V McMurray, Magnus Lindberg, John Wikstrand, John G F Cleland, Peter Dunselman

Eur J Heart Fail· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Henk W O Roeters van Lennep, An Ho Liem, Peter H J M Dunselman, Geesje M Dallinga-Thie, Aeilko H Zwinderman

Curr Med Res Opin· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
Tiny Jaarsma, Martje H L van der Wal, Ivonne Lesman-Leegte, Marie-Louise Luttik, Jochem Hogenhuis, Peter H J M Dunselman

Arch Intern Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
Bridget-Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer, Nicolas Danchin, Alexander Battler, Peter H J M Dunselman

Contemp Clin Trials· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosuvastatin in older patients with systolic heart failure.
John Kjekshus, Eduard Apetrei, Vivencio Barrios, Michael Böhm, John G F Cleland, Peter Dunselman

N Engl J Med· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course of isolated stable angina due to coronary heart disease.
Philip A Poole-Wilson, Zoltán Vokó, Bridget-Anne Kirwan, Sophie de Brouwer, Peter H J M Dunselman

Eur Heart J· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
Philip A Poole-Wilson, Bridget-Anne Kirwan, Zoltán Vokó, Sophie de Brouwer, Peter H J M Dunselman

J Clin Epidemiol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.
Johannes A Kragten, Peter H J M Dunselman

Expert Rev Cardiovasc Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.
Dirk J van Veldhuisen, Halfdan Aass, Dia El Allaf, Peter H J M Dunselman, Lars Gullestad

Eur J Heart Fail· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
J Wouter Jukema, An-Ho Liem, Peter H J M Dunselman, Jos A P van der Sloot, Dirk J A Lok

Curr Med Res Opin· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
John Kjekshus, Peter Dunselman, Malin Blideskog, Christina Eskilson, Ake Hjalmarson

Eur J Heart Fail· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early invasive versus selectively invasive management for acute coronary syndromes.
Robbert J de Winter, Fons Windhausen, Jan Hein Cornel, Peter H J M Dunselman, Charles L Janus

N Engl J Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
Jalal K Ghali, Peter Dunselman, Finn Waagstein, Sidney Goldstein, Stephen S Gottlieb

J Card Fail· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction.
Tom D J Smilde, Hans L Hillege, Adriaan A Voors, Peter H J Dunselman, Dirk J Van Veldhuisen

Am J Cardiol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The statin wars.
Peter Dunselman, Ake Hjalmarson, John Kjekshus, John McMurray, Finn Waagstein

Lancet· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis